Home › Funds › Palo Alto Investors LP › MDGL

Palo Alto Investors LP position in MDGL

MADRIGAL PHARMACEUTICALS INC · Health Care

Palo Alto Investors LP reported holding 1,787 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$901K, representing 0.13% of its reported portfolio and ranking #50 among its reported holdings. Palo Alto Investors LP has disclosed MDGL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.79K sh
Reported value held$900.58K
Portfolio Weight0.13%
First reportedQ1 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's MDGL position evolved

Palo Alto Investors LP first disclosed a stake in MDGL in Q1 2026 at 1,787 shares (US$935K). The position peaked in Q2 2026 at 1,787 shares, worth US$960K. Across 3 filings, Palo Alto Investors LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,787 shares valued at US$901K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.79K $935.44K New
Q2 2026 1.79K $959.53K Hold
Q3 2026 1.79K $900.58K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDGL and 13F data

MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.08B), Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$993.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDGL

All MDGL fund holders →

FAQ

How long has Palo Alto Investors LP held MDGL?

Palo Alto Investors LP has disclosed MDGL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Palo Alto Investors LP's current position in MDGL?

As of Q3 2026, Palo Alto Investors LP holds 1.79K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $900.58K, representing 0.13% of its reported portfolio and ranking #50.

Has Palo Alto Investors LP been buying or selling MDGL?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in MDGL. The position peaked in Q2 2026 at 1.79K shares.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, Jupiter Topco LLC, Janus Henderson Group, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.